Target-Based Design of Praziquantel Analogs at Cestode TRPM_PZQ

Area of Science:

• Parasitology
• Drug Discovery
• Molecular Biology

Background:

• Praziquantel (PZQ) is a key anthelmintic drug for treating flatworm infections.
• PZQ exhibits variable efficacy, with lower activity against pseudophyllidean cestodes.
• The drug targets parasitic flatworm transient receptor potential ion channels (TRPM_PZQ).

Purpose of the Study:

• To investigate the molecular basis for PZQ efficacy variation.
• To design novel PZQ analogs with enhanced activity against resistant parasites.
• To leverage target-based drug design for improved anthelmintic therapies.

Main Methods:

• Analyzing natural amino acid variations in cestode TRPM_PZQ binding pockets.
• Designing and synthesizing thioamide derivatives of PZQ.
• Evaluating the efficacy of new derivatives against pseudophyllidean cestode TRPM_PZQ.

Main Results:

• Identified key amino acid residues influencing PZQ binding and efficacy.
• Developed novel thioamide derivatives showing increased potency at pseudophyllidean cestode TRPM_PZQ.
• Demonstrated the potential of target-based design for overcoming PZQ resistance.

Conclusions:

• Natural variation in TRPM_PZQ contributes to differential PZQ sensitivity.
• Thioamide PZQ derivatives represent promising candidates for treating resistant cestode infections.
• Target-based design targeting TRPM_PZQ orthologues and paralogues can expand the anthelmintic drug arsenal.